Advertisement

European Radiology

, Volume 29, Issue 2, pp 645–653 | Cite as

Dose reference levels and clinical determinants in stroke neuroradiology interventions

  • Jad FarahEmail author
  • Aymeric Rouchaud
  • Theophraste Henry
  • Catherine Regen
  • Cristian Mihalea
  • Jacques Moret
  • Laurent Spelle
Interventional
  • 164 Downloads

Abstract

Objectives

To establish dose reference levels (RLs) for stroke interventions while carefully analysing the impact of clinical and technical parameters on patient exposure.

Methods

The study retrospectively analysed data from 377 stroke patients prospectively collected between 15 October 2015 and 30 March 2017 at a single, level-3 stroke centre equipped with Philips Allura Clarity systems. Local dose RLs were first derived as the 75th percentile of the dose area product (DAP), cumulative air kerma (Ka,r), fluoroscopy time (FT) and the number of images (NI). Univariate and multivariate negative binomial regressions were considered for the statistical analysis to investigate the dose variability with clinical and technical parameters such as patient’s age and sex, occlusion removal technique, number of passages, single-plane or biplane equipment, etc.

Results

Local stroke dose RLs were derived in terms of total DAP (162 Gy cm2), Ka,r (854 mGy), FT (42 min) and NI (559). Gender (relative dose multiplier (RDM) 1.31; 95% CI 1.12–1.45), number of passages (RDM 1.22 per passage; 95% CI 1.10–1.22) and procedure success (RDM 0.52, 95% CI 0.55–0.80) proved to be key parameters affecting patient dose. Meanwhile the statistical analysis did not find any difference in relative dose received by patients owing to age, baseline NIHSS score, occlusion removal technique, posterior circulation, support of an anaesthesiologist or use of biplane equipment.

Conclusions

Stroke dose RLs introduced in this work promote the optimisation of patient doses. Male gender, number of passages and success of recanalisation are independent key parameters affecting patient dose.

Key Points

• Stroke dose RLs derived in terms of total DAP (162 Gy cm 2 ), K a,r (854 mGy), FT (42 min) and NI (559) will help optimise the radiation safety of patients treated with mechanical thrombectomy.

• Male gender (relative dose multiplier 1.31; 95% CI 1.12–1.45), number of passages (RDM 1.22 per passage; 95% CI 1.10–1.22) and success of recanalisation TICI score > 2b (RDM 0.52, 95% CI 0.55–0.80) are independent key parameters affecting patient dose.

• Stent retriever or aspiration technique showed no significant difference in terms of the dose delivered to the patient; neither technique should be favoured for dosimetric reasons provided that there is no difference regarding clinical outcomes.

Keywords

Stroke Thrombectomy Radiation protection Patients Statistics 

Abbreviations

ALARA

As low as reasonably achievable

CI

Confidence interval

Ka,r

Cumulative air kerma at interventional reference point

DAP

Dose area product

DRLs

Diagnostic reference levels

FPCT

Flat-panel CT

FT

Fluoroscopy time

ICRP

International Commission on Radiological Protection

NI

Number of images

NIHSS

National Institutes of Health Stroke Scale

PACS

Picture Archiving and Communication System

RDM

Relative dose multiplier

RLs

Reference levels

SILC

Stroke Interventional Laboratory Consensus

TICI

Thrombolysis in cerebral infarction

Notes

Funding

The authors state that this work has not received any funding.

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Pr Laurent Spelle.

Conflict of interest

The authors of this manuscript declare relationships with the following companies: Philips, Medtronic, Stryker, MicroVention, Balt.

Statistics and biometry

One of the authors has significant statistical expertise.

Informed consent

As a follow-up evaluation on stroke patients, informed consent was not required.

Ethical approval

As a follow-up evaluation, the study did not involve any change in the standard procedure and did not require the identification of individuals.

Methodology

• retrospective

• observational

• performed at one institution

References

  1. 1.
    Saver JL, Goyal M, van der Lugt A et al (2016) Time to treatment with endovascular thrombectomy and outcomes from ischaemic stroke: a meta-analysis. JAMA 316:1279–1288CrossRefGoogle Scholar
  2. 2.
    Dávalos A, Cobo E, Molina CA et al (2017) Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial. Lancet Neurol 16:369–376CrossRefGoogle Scholar
  3. 3.
    Bracard S, Ducrocq X, Mas JL et al (2016) Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 15:1138–1147CrossRefGoogle Scholar
  4. 4.
    Goyal M, Menon BK, van Zwam WH et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387:1723–1731CrossRefGoogle Scholar
  5. 5.
    Campbell BCV, Donnan GA, Lees KR et al (2015) Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol 14:846–854CrossRefGoogle Scholar
  6. 6.
    Saver JL, Goyal M, Bonafe A et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372:2285–2295CrossRefGoogle Scholar
  7. 7.
    Campbell BC, Mitchell PJ, Kleinig TJ et al (2015) Endovascular therapy for ischaemic stroke with perfusion-imaging selection. N Engl J Med 372:1009–1018CrossRefGoogle Scholar
  8. 8.
    Goyal M, Demchuk AM, Menon BK et al (2015) Randomized assessment of rapid endovascular treatment of ischaemic stroke. N Engl J Med 372:1019–1030CrossRefGoogle Scholar
  9. 9.
    Nogueira R, Liebeskind D, Budzik RF et al (2017) Real-world applicability of endovascular therapy in ICA and/or MCA-M1 occlusions treated in the 6–24-hour window: subgroup analysis of the prospective Trevo registry. Eur Stroke J 2:477–495CrossRefGoogle Scholar
  10. 10.
    Jovin TG, Chamorro A, Cobo E et al (2015) Thrombectomy within 8 hours after symptom onset in ischaemic stroke. N Engl J Med 372:2296–2306CrossRefGoogle Scholar
  11. 11.
    Fransen PS, Berkhemer OA, Lingsma HF et al (2016) Time to reperfusion and treatment effect for acute ischaemic stroke: a randomized clinical trial. JAMA Neurol 73:190–196CrossRefGoogle Scholar
  12. 12.
    Figueiredo S, Carvalho A, Rodrigues M et al (2017) Endovascular stroke treatment of patients over 80 years old: cumulative evidence from the "real world". J Stroke Cerebrovasc Dis 26:2949–2953CrossRefGoogle Scholar
  13. 13.
    Dargazanli C, Consoli A, Gory B et al (2017) Is reperfusion useful in ischaemic stroke patients presenting with a low National Institutes of Health Stroke Scale and a proximal large vessel occlusion of the anterior circulation? Cerebrovasc Dis 43:305–312CrossRefGoogle Scholar
  14. 14.
    Haussen DC, Lima FO, Bouslama M et al (2017) Thrombectomy versus medical management for large vessel occlusion strokes with minimal symptoms: an analysis from STOPStroke and GESTOR cohorts. J Neurointerv Surg.  https://doi.org/10.1136/neurintsurg-2017-013243
  15. 15.
    Konstas AA, Minaeian A, Ross IB (2017) Mechanical thrombectomy in wake-up strokes: a case series using Alberta stroke program early CT score (ASPECTS) for patient selection. J Stroke Cerebrovasc Dis 26:1609-1614Google Scholar
  16. 16.
    Manceau PF, Soize S, Gawlitza M et al (2018) Is there a benefit of mechanical thrombectomy in patients with large stroke (DWI-ASPECTS</= 5)? Eur J Neurol 25:105–110CrossRefGoogle Scholar
  17. 17.
    Shams T, Zaidat O, Yavagal D, Xavier A, Jovin T, Janardhan V (2016) Society of Vascular and Interventional Neurology (SVIN) Stroke Interventional Laboratory Consensus (SILC) criteria: a 7M management approach to developing a stroke interventional laboratory in the era of stroke thrombectomy for large vessel occlusions. Interv Neurol 5:1–28Google Scholar
  18. 18.
    ICRP (1996) Radiological protection and safety in medicine: a report of the International Commission on Radiological Protection. Ann ICRP 26:1–47Google Scholar
  19. 19.
    Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ (2010) Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hair. Radiology 254:326–341Google Scholar
  20. 20.
    Vano E, Fernandez JM, Sanchez RM et al (2013) Patient radiation dose management in the follow-up of potential skin injuries in neuroradiology. AJNR Am J Neuroradiol 34:277–282CrossRefGoogle Scholar
  21. 21.
    Vano E, Järvinen H, Kosunen A et al (2008) Patient dose in interventional radiology: a European survey. Radiat Prot Dosimetry 129:39–45CrossRefGoogle Scholar
  22. 22.
    Miller DL, Kwon D, Bonavia GH (2009) Reference levels for patient radiation doses in interventional radiology: proposed initial values for US practice. Radiology 253:753–764CrossRefGoogle Scholar
  23. 23.
    Kien N, Rehel JL, Etard C, Aubert B (2011) Patient dose during interventional neuroradiology procedures: Results from a multi-center study. J Radiol 92:1101–1112Google Scholar
  24. 24.
    Vañó E, Miller DL, Martin CJ et al (2017) ICRP Publication 135: Diagnostic Reference Levels in Medical Imaging. Ann ICRP 46:1–144Google Scholar
  25. 25.
    Etard C, Bigand E, Salvat C et al (2017) Patient dose in interventional radiology: a multicentre study of the most frequent procedures in France. Eur Radiol 27:4281–4290CrossRefGoogle Scholar
  26. 26.
    Brown P, Cobb M, Smith T, A Zomorodi, L Gonzalez (2016) Fluoroscopy time and radiation dose in mechanical thrombectomy: a comparison of techniques. J Neurointerv Surg 8:A78–A79Google Scholar
  27. 27.
    Hassan AE, Amelot S (2017) Radiation exposure during neurointerventional procedures in modern biplane angiographic systems: a single-site experience. Interv Neurol 6:105–116CrossRefGoogle Scholar
  28. 28.
    Powers WJ, Derdeyn CP, Biller J et al (2015) 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischaemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46:3020–3035CrossRefGoogle Scholar
  29. 29.
    Wahlgren N, Moreira T, Michel P et al (2016) Mechanical thrombectomy in acute ischaemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke 11:134–147CrossRefGoogle Scholar
  30. 30.
    Rouchaud A, Pistocchi S, Blanc R, Engrand N, Bartolini B, Piotin M (2014) Predictive value of flat-panel CT for haemorrhagic transformations in patients with acute stroke treated with thrombectomy. J Neurointerv Surg 6:139–143Google Scholar
  31. 31.
    The R Foundation (2014) R: a language and environment for statistical computing. https://www.R-project.org
  32. 32.
    Agresti A (2002) Categorical data analysis, 2nd edn. Wiley, New YorkCrossRefGoogle Scholar
  33. 33.
    Iwanaga J, Watanabe K, Tsuyoshi S, Tabira Y, Yamaki K (2016) Tortuous common carotid artery: a report of four cases observed in cadaveric dissections. Case Rep Otolaryngol 2016:2028402Google Scholar
  34. 34.
    Muller MD, Ahlhelm FJ, von Hessling A et al (2017) Vascular anatomy predicts the risk of cerebral ischemia in patients randomized to carotid stenting versus endarterectomy. Stroke 48:1285–1292CrossRefGoogle Scholar
  35. 35.
    Jani B, Rajkumar C (2006) Ageing and vascular ageing. Postgrad Med J 82:357–362CrossRefGoogle Scholar
  36. 36.
    Lapergue B, Blanc R, Gory B et al (2017) Effect of endovascular contact aspiration vs stent retriever on revascularisation in patients with acute ischaemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA 318:443–452CrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2018

Authors and Affiliations

  1. 1.Hopitaux Universitaires Paris-Sud, Hopital du Kremlin-BicetreLe Kremlin-BicêtreFrance

Personalised recommendations